Variant report
Variant | nsv1021148 |
---|---|
Chromosome Location | chr8:5920859-5943185 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:5933019..5935981-chr8:5937353..5939270,2 | K562 | blood: | |
2 | chr8:5933019..5935981-chr8:5937353..5939270,2 | K562 | blood: | |
3 | chr8:5933019..5936001-chr8:5936013..5938853,2 | K562 | blood: | |
4 | chr8:5933019..5936001-chr8:5936013..5938853,2 | K562 | blood: | |
5 | chr8:5797855..5798416-chr8:5934095..5934883,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANGPT2-3 | chr8:5923520-5923650 | XLOC_006984 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ACVR2A | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs62494517 | chr8:5920924-5920925 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs577584632 | chr8:5920930-5920931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547211723 | chr8:5920950-5920951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141570655 | chr8:5920970-5920971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370810522 | chr8:5920974-5920975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183920378 | chr8:5921039-5921040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552864972 | chr8:5921071-5921072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188089843 | chr8:5921075-5921076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150912570 | chr8:5921078-5921079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77143876 | chr8:5921081-5921082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376395221 | chr8:5921084-5921085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138393534 | chr8:5921096-5921097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573406614 | chr8:5921097-5921098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535991232 | chr8:5921103-5921104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552740504 | chr8:5921108-5921109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369224574 | chr8:5921120-5921121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572727917 | chr8:5921131-5921132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72584119 | chr8:5921166-5921167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201675346 | chr8:5921167-5921168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73184675 | chr8:5921168-5921169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78783738 | chr8:5921212-5921213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142974462 | chr8:5921230-5921231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77252777 | chr8:5921237-5921238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371429813 | chr8:5921240-5921241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193093182 | chr8:5921253-5921254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs59364526 | chr8:5921262-5921263 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs550862232 | chr8:5921278-5921279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570485260 | chr8:5921311-5921312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113329913 | chr8:5921317-5921318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527922265 | chr8:5921397-5921398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545486035 | chr8:5923217-5923218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187904176 | chr8:5923261-5923262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192542120 | chr8:5923274-5923275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369350229 | chr8:5923284-5923285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549512176 | chr8:5923295-5923296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552301991 | chr8:5923302-5923303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541980953 | chr8:5923308-5923309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs714453 | chr8:5923322-5923323 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs553889242 | chr8:5923337-5923338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73184678 | chr8:5923340-5923341 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs547681099 | chr8:5923343-5923344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149039041 | chr8:5923350-5923351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184976074 | chr8:5923374-5923375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533304654 | chr8:5923432-5923433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187407829 | chr8:5923462-5923463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs386721688 | chr8:5923471-5923472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2897873 | chr8:5923472-5923473 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs199920048 | chr8:5923489-5923490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs397946926 | chr8:5923498-5923499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556675350 | chr8:5923510-5923511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20688739 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5918000-5921000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr8:5921000-5921400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr8:5923200-5925200 | Enhancers | Fetal Brain Male | brain |
4 | chr8:5923600-5923800 | Enhancers | Brain Inferior Temporal Lobe | brain |
5 | chr8:5923600-5924000 | Enhancers | Fetal Brain Female | brain |
6 | chr8:5929800-5930800 | Enhancers | Fetal Heart | heart |
7 | chr8:5930800-5934200 | Weak transcription | Fetal Heart | heart |
8 | chr8:5931400-5932600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr8:5932000-5932400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr8:5932000-5932400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr8:5932600-5935800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr8:5934000-5934200 | Active TSS | Brain Hippocampus Middle | brain |
13 | chr8:5934200-5934400 | Flanking Active TSS | Brain Hippocampus Middle | brain |
14 | chr8:5934200-5934600 | Enhancers | Brain Anterior Caudate | brain |
15 | chr8:5934200-5934800 | Enhancers | Fetal Heart | heart |
16 | chr8:5934400-5934600 | Enhancers | Adipose Nuclei | Adipose |
17 | chr8:5934400-5934800 | Enhancers | Fetal Brain Male | brain |
18 | chr8:5935800-5936800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr8:5936200-5936600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
20 | chr8:5942800-5943200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |